| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTCT over the last quarter tilts toward selling: insiders offloaded a net 112,078 shares worth roughly $7.8M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTCT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.29M | $77.68M | -5,000 | |
| CEO | 383.9K | $26.32M | - | |
| VP | 105.3K | $6.76M | -2,265 | |
| CFO | 84.0K | $6.75M | - | |
| VP | 79.1K | $5.38M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Okey Stephanie55 | Director | Sale+OE10b5-1 | 15,167 | $70.00 | $1,061,690.00 | -65.5% | +3.4% | - | |
| Mar 5, 2026 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sell10b5-1 | 3,989 | $63.38 | $252,822.82 | -59.3% | +8.4% | - | |
| Mar 5, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell10b5-1 | 10,000 | $63.38 | $633,800.00 | -11.1% | +8.4% | - | |
| Mar 5, 2026 | Okey Stephanie55 | Director | Sell10b5-1 | 6,333 | $63.38 | $401,385.54 | -44.2% | +8.4% | - | |
| Feb 19, 2026 | Boulding Mark Elliott56 | Executive VP and CLO | Sell10b5-1 | 3,019 | $69.48 | $209,762.58 | -2.8% | +1.6% | - | |
| Feb 18, 2026 | Almstead Neil Gregory55 | Chief Technical Ops Officer | Sell10b5-1 | 3,121 | $69.36 | $216,472.56 | -2.6% | +2.0% | - | |
| Feb 18, 2026 | Golden Lee Scott | EVP &Chief Medical Officer | Sell10b5-1 | 2,484 | $69.36 | $172,290.24 | -2.7% | +2.0% | - | |
| Feb 18, 2026 | Gravier Pierre55 | Chief Financial Officer | Sell10b5-1 | 2,992 | $69.36 | $207,525.12 | -3.3% | +2.0% | - | |
| Feb 18, 2026 | Pauwels Eric61 | Chief Business Officer | Sell10b5-1 | 3,019 | $69.36 | $209,397.84 | -3.8% | +2.0% | - | |
| Feb 18, 2026 | Klein Matthew B.53 | Chief Executive Officer | Sell10b5-1 | 7,371 | $69.36 | $511,252.56 | -1.9% | +2.0% | - |